Practice Parameter: Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease (An Evidence-Based Review)
Neurol 66:996-1002, Miyasaki,J.M.,et al, 2006
The Parkinsons Complex: Parkinsonism Is Just the Tip of the Iceberg
Ann Neurol 59:591-596, Langston,J.W., 2006
Stroke in Childhood
The Neurologist 12:94-102, Jordan,L.C., 2006
Effect of Enhanced Psychosocial Care on Antipsychotic Use in Nursing Home Residents with Severe Dementia; Cluster Randomised Trial
BMJ 332:756-758,741, Fossey,J.,et al, 2006
Donepezil in Patients with Severe Alzheimers Disease: Double-Blind, Parallel-Group, Placebo-Controlled Study
Lancet 367:1057-1065,1031, Winblad,B.,et al, 2006
Frontotemporal Lobar Degeneration with Motor Neuron Disease
Arch Neurol 63:489-490, Clark,C.M. &Forman,M.S., 2006
Mild Cognitive Impairment
Lancet 367:1262-1270, Gauthier,S.,et al, 2006
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Arch Neurol 63:665-672,645, Petersen,R.C.,et al, 2006
Sleep-wake Disturbances in Sporadic Creutzfeldt-Jakob Disease
Neurol 66:1418-1424, Landolt,H.-P.,et al, 2006
Coxibs and Alzheimers Disease: Should They Stay or Should They Go?
Ann Neurol 59:219-228, Firuzi,O. &Pratico,D., 2006
First Symptom in Sporadic Creutzfeldt-Jakob Disease
Neurol 66:286-287, Rabinovici,G.D.,et al, 2006
Multiple-Level Studies Are Needed to Assess the True Value of Diagnostic Tests for Dementia
Arch Neurol 63:142-143,146, Van Gool,W.A., 2006
Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006
Mild Cognitive Impariment is Early-Stage Alzheimer Disease
Arch Neurol 63:15-16, Morris,J.C., 2006
A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006
Prevalence of Fabry Disease in Patients with Cryptogenic Stroke: A Prospective Study
Lancet 366:1794-1796,1754, Rolfs,A.,et al, 2006
Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006
Risk Factors for Variant Creutzfeldt-Jakob Disease: A Case-Control Study
Ann Neurol 59:111-120, Ward,H.J.T.,et al, 2006
Incidence and Causes of Nondegenerative Nonvascular Dementia
Arch Neurol 63:218-221, Knopman,D.S.,et al, 2006
Delirium in Older Persons
NEJM 354:1157-1165, Inouye,S.K., 2006
Clinicopath Conf., MELAS Syndrome
NEJM 353:2271-2280, Case 36-2005, 2005
Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Global Prevalence of Dementia: A Delphi Consensus Study
Lancet 366:2112-2117, Ferri,C.P.,et al, 2005
Diagnosis and Management of Dementia with Lewy Bodies
Neurol 65:1863-1872, McKeith,I.G.,et al, 2005
Discontinuing Prophylactic Transfusions Used to Preven Stroke in Sickle Cell Disease
NEJM 353:2769-2778,2743, The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005
Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
Arch Neurol 62:753-757, Sparks,D.L.,et al, 2005
Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances
Dept Health & Human Services (Apr), FDA Public Health Advisory, 2005
Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005
The "Pulvinar Sign" in a Case of Paraneoplastic Limbic Encephalitis Associated with Non-Hodgkins Lymphoma
JNNP 76:882-884, Mihara,M.,et al, 2005
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005
Frontotemporal Lobar Degeneration
Arch Neurol 62:925-930, Johnson,J.K.,et al, 2005
Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease:High Sensitivity and Specificity for Diagnosis
AJNR 26:1551-1562, Young,G.S.,et al, 2005
A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease
Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005
Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005
Different Patterns of Magnetic Resonance Imaging Atrophy for Frontotemporal Lobar Degeneration Syndromes
Arch Neurol 62:1106-1110, Short,R.A.,et al, 2005
Delusions and Hallucinations in Dementia with Lewy Bodies: Worsening with Memantine
Neurol 65:481-482, Ridha,B.H.,et al, 2005
The Spectrum of Presentations of Venous Infarction Caused by Deep Cerebral Vein Thrombosis
Neurol 65:192-196, van den Bergh,W.M.,et al, 2005
Creutzfeldt-Jakob Disease Mimicking Radiologic Posterior Reversible Leukoencephalopathy
Neurol 65:329, Sibon,I.,et al, 2005
Ischaemic Stroke in Young Adults: Predictors of Outcome and Recurrence
JNNP 76:191-195, Nedeltchev, K., et al, 2005
Genetic Factors in Alzheimer's Disease
NEJM 352: 862-863, 884, Bird, T., 2005
Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005
Steroid Dementia: an Overlooked Diagnosis?
Neurol 64:707-709, Sacks,O. & Shulman,M., 2005
Specialist Palliative Care in Dementia
BMJ 330:57-58, Chen,F. & Majeed,A., 2005
Recurrent Stroke Associated With Cannabis Use
JNNP 76:435-437, Mateo,I., et al, 2005
Recent Developments in Pain in Dementia
BMJ 330:461-464, Scherder,E., et al, 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Recurrent Stroke Associated with Cannabis Use
JNNP 76:435-437, Mateo,I.,et al, 2005
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005